RBQMLive, Sponsored by CluePoints, Wins Prestigious Sales and Marketing Award
Two-day educational conference tops the experiential/event marketing category at the Sales and Marketing Technology Awards 2023 King of Prussia, PA – August 9, 2023: CluePoints,…
Read More
How to Leverage Machine Learning & Deep Learning for Natural Language Processing in Clinical Trials
Machine learning (ML) and deep learning (DL) are transforming natural language processing (NLP). A key use case is medical coding. ML models can significantly reduce…
Read More
Expert Speaker Lineup Revealed for Award Winning RBQM Event
Full agenda and keynote speakers announced for industry-leading risk-based quality management event focusing on the global transformation and evolution of RBQM, sponsored by CluePoints. King…
Read More
CluePoints, Ken Getz & Tufts CSDD and PwC Unveil New RBQM Insights Report at DIA Global Annual Meeting 2023
CluePoints and partners present and discuss the results of a new study examining RBQM use and adoption. King of Prussia, PA – June 20, 2023: CluePoints, the…
Read More
How to Leverage AI for High-Quality Clinical Trials
The average Phase III study generates a staggering 3.4 million data points1—more than any human could ever hope to analyze in a lifetime. The advent…
Read More
Enhancing RBQM with Artificial Intelligence: Your Questions Answered
With traditional approaches to clinical trial data management being manual, cumbersome, and prone to human error, streamlining processes offers huge efficiency- and quality-boosting potential. Risk-based…
Read More
CluePoints Supports Launch of RBQM Live 2023 as Premier Event Sponsor
Registration for must-attend Risk-Based Quality Management event is now open King of Prussia, PA – May 3, 2023: CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Risk-Based Quality…
Read More
CluePoints Announces Amit Patel as New CFO
Organizational changes support rapid growth, scale, and focus for RBQM leader King of Prussia, PA – April 5th, 2023: RBQM leader, CluePoints, has today announced…
Read More
Events
Find out where we’re headed next.
Featured Whitepaper
ICH E6 (R2)
Summary
Paper
Created in conjunction with our peers at TUFTS Center for the Study of Drug Development, this paper provides insights on how companies are responding to ICH E6 (R2) and information on the key themes on adoption.
Featured Webinar
ICH E6 (R2)
Webinar
Series
This recorded webinar covers all of the frequently asked Questions about ICH E6 (R2), Risk-Based Study Execution (RBx) and what’s required from a people, process & technology standpoint.
We're Kind of a Big Deal.
7,000
Platform Users
1,200
Studies De-Risked
100,000
Issues Detected